Contrast-induced renal disease in renal patients

Not Applicable

Recruiting

• Conditions: Acute kidney injury; Peripheral arterial disease; Kidney Diseases; C12.950.419.780

• Registration Number: RBR-3h2gv8r
• Lead Sponsor: Hospital Geral de Goiania dr Alberto Rassi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-03-31
• Last Update Posted: 29 May 2023
• Study Completion: 2023-12-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients hospitalized due to peripheral obstructive arterial disease requiring
contrast tests (diagnostic and/or therapeutic arteriographies only); Completion of the Free and Informed Consent Form (FICT); Patients with normal renal function (GFR greater than 60 ml/min/1.73m2) to compose the control group; Patients with changes in renal function compatible with moderate chronic kidney disease (GFR between 30-59 ml/min/1.73m2) or severe chronic kidney disease (GFR less than 30 ml/min/1.73m2)

Exclusion Criteria

Patients with: congestive heart failure, septic or cardiogenic shock; Patients who used nephrotoxic medications or iodinated contrast in the 48-hour period before the evaluation; Patients with acute kidney injury or chronic kidney disease on dialysis

Study & Design

• Study Type: Intervention
• Study Design: Not specified